Literature DB >> 16695795

EFFECTS OF ADRENOCORTICOTROPHIC HORMONE ON NEURO-MUSCULAR FUNCTION IN PATIENTS WITH MYASTHENIA GRAVIS.

C Torda1, H G Wolff.   

Abstract

Entities:  

Keywords:  MYASTHENIA/gravis; PITUITARY PREPARATIONS

Mesh：

Substances：

Year:  1949        PMID： 16695795      PMCID： PMC439680          DOI： 10.1172/JCI102157

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  4 in total

1.  EFFECT OF BLOOD SERUM FROM PATIENTS WITH MYASTHENIA GRAVIS ON THE SYNTHESIS OF ACETYLCHOLINE IN VITRO.

Authors:  C Torda; H G Wolff
Journal:  J Clin Invest       Date:  1944-09       Impact factor: 14.808

2.  Acetylcholine Synthesis.

Authors:  C Torda; H C Wolff
Journal:  Science       Date:  1946-05-24       Impact factor: 47.728

3.  THE NATURE OF MYASTHENIA GRAVIS.

Authors:  C Torda; H G Wolff
Journal:  Science       Date:  1943-09-03       Impact factor: 47.728

4.  EFFECT OF SPINAL FLUID FROM PATIENTS WITH MYASTHENIA GRAVIS ON THE SYNTHESIS OF ACETYLCHOLINE IN VITRO.

Authors:  C Torda; H G Wolff
Journal:  Science       Date:  1944-09-01       Impact factor: 47.728
  4 in total
  8 in total

1.  [The effect of adrenal cortex hormones on single nerve cells in the spinal cord of cats. An experimental contribution to the mechanism of action of prednisolone in the therapy of central nervous system diseases].

Authors:  F J SCHULTE; H ten BRUGGENCATE
Journal:  Klin Wochenschr       Date:  1962-09-01

2.  [Studies on the pathophysiology and therapy of myotonias with special reference to electrolyte balance].

Authors:  H G MERTENS; R GRUTTNER
Journal:  Klin Wochenschr       Date:  1955-07-01

3.  Diseases and disorders of muscle function.

Authors:  D McEACHERN
Journal:  Bull N Y Acad Med       Date:  1951-01

4.  Myasthenia gravis, ulcerative colitis and lichen planus.

Authors:  T N Miller
Journal:  Proc R Soc Med       Date:  1971-08

Review 5.  Immunopathology of acetylcholine receptors in myasthenia gravis.

Authors:  M E Seybold; J M Lindstrom
Journal:  Springer Semin Immunopathol       Date:  1982

6.  Controversies about the treatment of myasthenia gravis.

Authors:  L P Rowland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

7.  Treatment of ocular myasthenia with corticotrophin.

Authors:  F B Gibberd; F Navab; C L Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-02       Impact factor: 10.154

8.  Intravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis.

Authors:  Laura Díez-Porras; Christian Homedes; Maria Antonia Alberti; Valentina Vélez-Santamaría; Carlos Casasnovas
Journal:  Sci Rep       Date:  2020-08-11       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.